Equities

Bon Natural Life Ltd

BON:NAQ

Bon Natural Life Ltd

Actions
Basic MaterialsChemicals
  • Price (USD)1.80
  • Today's Change-0.013 / -0.70%
  • Shares traded36.47k
  • 1 Year change-58.24%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 20:50 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Bon Natural Life Ltd is a China-based company principally engaged in the manufacturing and sales of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements, such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. The Company's product categories include fragrance compounds, health supplements (natural, functional active ingredients for powder drinks) and bioactive food ingredients. Fragrance compounds product category includes clary sage extract products. Bioactive food ingredients include stachyose, milk thistle extracts, apple extracts, phloretin and pomegranate extract products. The Company’s products are applied in the functional food, personal care, cosmetic and pharmaceutical industries.

  • Revenue in USD (TTM)29.52m
  • Net income in USD4.60m
  • Incorporated2019
  • Employees96.00
  • Location
    Bon Natural Life LtdC601, Gazelle Valley, No.69Jinye Rd., Xi'an-Tech ZoneXI'AN 710076ChinaCHN
  • Phone+86 2 988346301
  • Websitehttps://www.bnlus.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Processa Pharmaceuticals Inc0.00-10.22m4.62m13.00--0.6763-----5.36-5.360.002.100.00----0.00-115.58-84.35-133.48-90.03------------0.0016------59.45---34.05--
GT Biopharma Inc0.00-11.35m4.87m2.00--0.8845-----7.72-7.720.002.470.00----0.00-82.84-205.36-120.73--------------0.00------63.62------
CYANOTECH CORP23.82m-5.10m4.87m77.00--0.4563--0.2045-0.7549-0.75493.561.530.88952.0512.12309,389.60-19.04-3.46-29.60-4.4624.7234.54-21.41-3.580.3354-6.610.377---0.4616-5.24-53.11---6.42--
AgriFORCE Growing Systems Ltd57.60k-15.05m4.91m7.00--0.3873--85.17-5.81-5.810.00370.13430.0034--1.218,228.57-88.79-78.95-124.14-109.8617.86---26,121.49-243,182.501.24-1.280.0789------8.85--48.61--
Titan Pharmaceuticals Inc4.00k-5.46m5.17m4.00--1.30--1,293.64-6.59-6.590.00494.370.0016--0.17021,000.00-211.58-96.80-368.99-156.65-----136,525.00-406.26---309.960.00---66.97-51.1645.43---65.61--
Sonnet Biotherapeutics Holdings Inc55.89k-7.99m5.20m12.00--1.99--93.08-3.02-3.020.01440.50170.0071--0.08814,657.50-100.88---255.30-------14,287.67-----331.070.00---57.76--36.64------
Cannapharmarx Inc25.84k627.24k5.83m21.00----8.39225.62-0.0061-0.00610.00006-0.02540.003--0.16541,230.487.36-131.06-----1,692.76--2,427.40--0.0123-0.2483--------143.24------
Integrated BioPharma, Inc.50.57m-116.00k6.77m141.00--0.357831.920.1338-0.0041-0.00411.670.62831.884.4510.76358,617.00-0.43115.54-0.569828.007.0912.09-0.22946.451.02-9.000.001---9.913.00-100.42---14.03--
Coeptis Therapeutics Holdings Inc0.00-16.14m6.97m5.00---------0.5143-0.51430.00-0.01110.00----0.00-284.35-37.29-709.12-38.23------------1.22------43.40------
Hoth Therapeutics Inc0.00-7.46m6.97m2.00--0.5795-----1.69-1.690.001.740.00----0.00-67.99-157.07-76.33-177.32------------0.00------31.01------
Biofrontera Inc35.24m-13.51m7.15m85.00--0.6023--0.2029-5.29-5.2912.122.141.211.977.27414,623.50-46.20---113.24--47.75---38.33--1.46-3.530.0264--18.82---3,045.47------
Bon Natural Life Ltd29.52m4.60m7.20m96.000.36330.061.310.24384.994.9932.1030.230.704515.275.19307,524.6010.8614.0413.6920.6829.9430.0015.4217.622.4130.540.09550.00-1.2922.32-26.3283.09-6.70--
CV Sciences Inc15.85m-2.53m8.31m42.00--3.31--0.5244-0.0157-0.01570.0980.01391.691.5525.35377,285.70-26.94-43.42-73.44-77.7546.0651.81-15.95-45.680.2530--0.0114---1.24-19.80133.96-20.87----
Bioquest Corp0.00-507.41k8.61m-----------0.0485-0.04850.00-0.04670.00-------3,483.76-----------------3.88--------64.67------
Data as of Sep 19 2024. Currency figures normalised to Bon Natural Life Ltd's reporting currency: US Dollar USD

Institutional shareholders

4.95%Per cent of shares held by top holders
HolderShares% Held
UBS Securities LLCas of 30 Jun 202468.96k4.95%
Citadel Securities LLCas of 30 Jun 20240.000.00%
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.